Medical University of Lodz   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Lods Poland (2002)

Organization Overview

First Clinical Trial
2003
NCT01555736
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

Barlicki University Hospital, Medical University of Lodz (Poland) | Centre for Family and Community Medicine, Medical Univeristy of Lodz, Poland | Department of Affective and Psychotic Disorders Medical University of Lodz | Department of Affective and Psychotic Disorders, Medical University of Lodz | Department of Clinical Nutrition and Gastroenterological Diagnostics | Department of Hypertension UM Lodz | Department of Pediatrics and Allergy, Medical University of Lodz, Lodz, Poland | Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland | Department of Pediatrics and Allergy, Medical University of Lodz, N. Copernicus Hospital, Lodz, Poland. | Department of Pediatrics and Allergy, Medical University of Lodz, Poland | Department of Pneumonology and Allergy, Medical University of Lodz, Poland | Department of Rehabilitation and Physical Medicine, Medical University of Lodz | Medical University in Lodz | Medical University Lodz | Medical University of Lodz | Medical University of Łódź | Medical University of Lodz Poland | Medical University of Lodz, Poland | Medical Universtity of Lodz | Poland: Medical University Lodz, Department of Nephrology | University Hospital, Lodz, Poland | Uniwersytecki Spital | Uniwersytecki Szpital Kliniczny Nr1, Lodz, Poland | Uniwersytecki Szpital, Lodz

Active Ingredients

Drugs in Phase 4 Trials (25)

acetylsalicylic acid (aspirin) (1 trial)

albuterol (proventil) (1 trial)

budesonide (rhinocort) (4 trials)

cetirizine (zyrtec) (3 trials)

clopidogrel (plavix) (1 trial)

dabigatran (pradaxa) (1 trial)

dexamethasone (1 trial)

fatty acid (1 trial)

formoterol (foradil) (6 trials)

house dust mite allergen (4 trials)

ivabradine (corlanor) (1 trial)

lanthanum (1 trial)

levosimendan (1 trial)

melatonin (2 trials)

menaquinone (vitamin k2) (1 trial)

methenamine (1 trial)

mometasone (elocon) (1 trial)

montelukast (singulair) (6 trials)

olive (1 trial)

rye pollens (1 trial)

sevelamer (renagel) (1 trial)

sitagliptin (januvia) (1 trial)

ticagrelor (brilinta) (1 trial)

timothy grass pollen allergen extract (Grastek) (3 trials)

vitamin d3 (3 trials)

Drugs in Phase 3 Trials (7)

bifidobacterium longum (1 trial)

bilastine (3 trials)

desloratadine (clarinex) (1 trial)

ketosteril (1 trial)

lactobacillus helveticus (1 trial)

lactose (1 trial)

prednisone (meticorten) (1 trial)

Drugs in Phase 2 Trials (8)

azd-3199 (1 trial)

bifidobacteria (1 trial)

ciclesonide (alvesco) (1 trial)

ciprofloxacin (cipro) (1 trial)

finafloxacin (xtoro) (1 trial)

modified recombinant fish parvalbumin (1 trial)

sarcosine (1 trial)

trifolium pratense (1 trial)

Drugs in Phase 1 Trials (3)

apocynin (2 trials)

beclomethasone (vanceril) (2 trials)

glycopyrronium (robinul) (2 trials)

Drugs in Other Trials (16)

amoxicillin (1 trial)

atropine (1 trial)

cocoa powder (1 trial)

empagliflozin (jardiance) (1 trial)

eprosartan (teveten) (1 trial)

fish oil (Omegavan) (2 trials)

lactisole (1 trial)

lactobacillus rhamnosus (1 trial)

levofloxacin (levaquin) (1 trial)

losartan (cozaar) (1 trial)

maltodextrin (1 trial)

Narsoplimab (1 trial)

pantoprazole (protonix) (1 trial)

r-isoprenaline (1 trial)

saccharomyces boulardii (1 trial)

sodium butyrate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acute Coronary Syndrome (Phase 4)

Asthma (Phase 4)

Atrial Fibrillation (Phase 4)

Calcinosis (Phase 4)

Conjunctivitis (Phase 2)

Diabetes, Gestational (Phase 4)

Diabetes Mellitus (Phase 4)

Dysphonia (Phase 4)

Food Hypersensitivity (Phase 2)

Hoarseness (Phase 4)

Hypersensitivity (Phase 2)

Hypocalcemia (Phase 4)

Hypoparathyroidism (Phase 4)

Infections (Phase 4)

Inflammation (Phase 4)

Kidney Diseases (Phase 4)

Liver Diseases (Phase 4)

Lung Diseases (Phase 4)

Lung Diseases, Obstructive (Phase 4)

Nausea (Phase 4)

Pain, Postoperative (Phase 4)

Postoperative Complications (Phase 4)

Postoperative Nausea and Vomiting (Phase 4)

Pulmonary Disease, Chronic Obstructive (Phase 4)

Pyelonephritis (Phase 2)

Renal Insufficiency, Chronic (Phase 4)

Rhinitis (Phase 4)

Rhinitis, Allergic (Phase 4)

Rhinitis, Allergic, Perennial (Phase 3)

Rhinitis, Allergic, Seasonal (Phase 4)

Schizophrenia (Phase 4)

Sinusitis (Phase 4)

Syndrome (Phase 4)

Urinary Tract Infections (Phase 4)

Vitamin D Deficiency (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 51
  • # of Trial APIs: 59